vs
Side-by-side financial comparison of Outdoor Holding Co (POWW) and STRATA Skin Sciences, Inc. (SSKN). Click either name above to swap in a different company.
Outdoor Holding Co is the larger business by last-quarter revenue ($13.4M vs $9.3M, roughly 1.4× STRATA Skin Sciences, Inc.). Outdoor Holding Co runs the higher net margin — 16.7% vs 0.6%, a 16.0% gap on every dollar of revenue. On growth, STRATA Skin Sciences, Inc. posted the faster year-over-year revenue change (-3.0% vs -54.1%). Outdoor Holding Co produced more free cash flow last quarter ($5.0M vs $-551.0K).
Vista Outdoor Inc. was an American designer, manufacturer, and marketer that operated in two segments: shooting sports and outdoor products. It was a "house of brands" with more than 40 labels and subsidiaries.
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
POWW vs SSKN — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.4M | $9.3M |
| Net Profit | $2.2M | $58.0K |
| Gross Margin | 87.1% | 61.8% |
| Operating Margin | 14.7% | 5.3% |
| Net Margin | 16.7% | 0.6% |
| Revenue YoY | -54.1% | -3.0% |
| Net Profit YoY | 108.5% | 101.3% |
| EPS (diluted) | $0.01 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.4M | $9.3M | ||
| Q3 25 | $12.0M | $6.9M | ||
| Q2 25 | $11.9M | $7.7M | ||
| Q1 25 | $12.6M | $6.8M | ||
| Q4 24 | $12.5M | $9.6M | ||
| Q3 24 | $12.0M | $8.8M | ||
| Q2 24 | $12.3M | $8.4M | ||
| Q1 24 | $-50.7M | $6.8M |
| Q4 25 | $2.2M | $58.0K | ||
| Q3 25 | $1.4M | $-1.6M | ||
| Q2 25 | $-6.5M | $-2.6M | ||
| Q1 25 | $-77.5M | $-2.1M | ||
| Q4 24 | $-26.1M | $-4.6M | ||
| Q3 24 | $-12.4M | $-2.1M | ||
| Q2 24 | $-14.8M | $-91.0K | ||
| Q1 24 | $-5.2M | $-3.4M |
| Q4 25 | 87.1% | 61.8% | ||
| Q3 25 | 87.1% | 60.4% | ||
| Q2 25 | 87.2% | 56.2% | ||
| Q1 25 | 87.5% | 53.5% | ||
| Q4 24 | 87.4% | 61.4% | ||
| Q3 24 | 86.9% | 60.1% | ||
| Q2 24 | 85.8% | 59.0% | ||
| Q1 24 | — | 45.6% |
| Q4 25 | 14.7% | 5.3% | ||
| Q3 25 | 5.9% | -16.9% | ||
| Q2 25 | -50.7% | -30.1% | ||
| Q1 25 | -213.6% | -25.0% | ||
| Q4 24 | -163.8% | -44.7% | ||
| Q3 24 | -50.3% | -18.2% | ||
| Q2 24 | -50.8% | -5.7% | ||
| Q1 24 | — | -42.7% |
| Q4 25 | 16.7% | 0.6% | ||
| Q3 25 | 11.7% | -23.4% | ||
| Q2 25 | -54.5% | -33.6% | ||
| Q1 25 | -614.5% | -31.2% | ||
| Q4 24 | -208.7% | -47.6% | ||
| Q3 24 | -103.7% | -23.6% | ||
| Q2 24 | -120.2% | -1.1% | ||
| Q1 24 | 10.3% | -49.8% |
| Q4 25 | $0.01 | $0.14 | ||
| Q3 25 | $0.01 | $-0.36 | ||
| Q2 25 | $-0.06 | $-0.62 | ||
| Q1 25 | $-0.67 | $-0.51 | ||
| Q4 24 | $-0.23 | $-2.01 | ||
| Q3 24 | $-0.11 | $-0.51 | ||
| Q2 24 | $-0.13 | $-0.03 | ||
| Q1 24 | $-0.05 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $69.9M | $7.9M |
| Total DebtLower is stronger | — | $15.3M |
| Stockholders' EquityBook value | $237.3M | $2.9M |
| Total Assets | $271.7M | $30.5M |
| Debt / EquityLower = less leverage | — | 5.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $69.9M | $7.9M | ||
| Q3 25 | $65.7M | $7.1M | ||
| Q2 25 | $63.4M | $6.0M | ||
| Q1 25 | $30.2M | $6.5M | ||
| Q4 24 | $31.9M | $7.3M | ||
| Q3 24 | $33.5M | $7.1M | ||
| Q2 24 | $50.8M | $5.5M | ||
| Q1 24 | $55.6M | $5.2M |
| Q4 25 | — | $15.3M | ||
| Q3 25 | — | $15.3M | ||
| Q2 25 | — | $15.0M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $15.0M | ||
| Q3 24 | — | $15.0M | ||
| Q2 24 | — | $15.0M | ||
| Q1 24 | — | $15.0M |
| Q4 25 | $237.3M | $2.9M | ||
| Q3 25 | $235.4M | $1.3M | ||
| Q2 25 | $222.5M | $532.0K | ||
| Q1 25 | $222.0M | $3.0M | ||
| Q4 24 | $299.6M | $5.0M | ||
| Q3 24 | $325.6M | $9.4M | ||
| Q2 24 | $342.5M | $9.5M | ||
| Q1 24 | $358.0M | $9.4M |
| Q4 25 | $271.7M | $30.5M | ||
| Q3 25 | $270.3M | $30.7M | ||
| Q2 25 | $269.5M | $29.5M | ||
| Q1 25 | $297.3M | $33.0M | ||
| Q4 24 | $355.4M | $34.9M | ||
| Q3 24 | $368.9M | $39.4M | ||
| Q2 24 | $398.6M | $38.8M | ||
| Q1 24 | $403.0M | $39.2M |
| Q4 25 | — | 5.28× | ||
| Q3 25 | — | 11.65× | ||
| Q2 25 | — | 28.20× | ||
| Q1 25 | — | 5.04× | ||
| Q4 24 | — | 3.02× | ||
| Q3 24 | — | 1.60× | ||
| Q2 24 | — | 1.58× | ||
| Q1 24 | — | 1.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.7M | $-239.0K |
| Free Cash FlowOCF − Capex | $5.0M | $-551.0K |
| FCF MarginFCF / Revenue | 37.6% | -5.9% |
| Capex IntensityCapex / Revenue | 4.8% | 3.4% |
| Cash ConversionOCF / Net Profit | 2.55× | -4.12× |
| TTM Free Cash FlowTrailing 4 quarters | $-2.3M | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.7M | $-239.0K | ||
| Q3 25 | $3.2M | $-64.0K | ||
| Q2 25 | $-6.7M | $-1.9M | ||
| Q1 25 | $-1.5M | $-550.0K | ||
| Q4 24 | $1.3M | $703.0K | ||
| Q3 24 | $-9.3M | $-302.0K | ||
| Q2 24 | $-547.5K | $591.0K | ||
| Q1 24 | $4.3M | $-804.0K |
| Q4 25 | $5.0M | $-551.0K | ||
| Q3 25 | $2.5M | $-1.1M | ||
| Q2 25 | $-7.6M | $-2.0M | ||
| Q1 25 | $-2.3M | $-749.0K | ||
| Q4 24 | $720.3K | $199.0K | ||
| Q3 24 | $-10.6M | $-364.0K | ||
| Q2 24 | $-1.3M | $246.0K | ||
| Q1 24 | $1.4M | $-1.5M |
| Q4 25 | 37.6% | -5.9% | ||
| Q3 25 | 21.0% | -15.6% | ||
| Q2 25 | -63.8% | -26.1% | ||
| Q1 25 | -18.6% | -11.0% | ||
| Q4 24 | 5.8% | 2.1% | ||
| Q3 24 | -88.3% | -4.1% | ||
| Q2 24 | -11.0% | 2.9% | ||
| Q1 24 | -2.8% | -22.6% |
| Q4 25 | 4.8% | 3.4% | ||
| Q3 25 | 5.8% | 14.7% | ||
| Q2 25 | 7.5% | 0.8% | ||
| Q1 25 | 6.5% | 2.9% | ||
| Q4 24 | 4.4% | 5.3% | ||
| Q3 24 | 10.4% | 0.7% | ||
| Q2 24 | 6.5% | 4.1% | ||
| Q1 24 | -5.7% | 10.7% |
| Q4 25 | 2.55× | -4.12× | ||
| Q3 25 | 2.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
POWW
Segment breakdown not available.
SSKN
| Dermatology Recurring Procedures | $6.1M | 65% |
| Dermatology Procedures Equipment | $3.2M | 35% |
